Open-Label Extension and Safety Study of Talazoparib
Clinical trial NCT02921919 · COMPLETED
Trial details
- NCT number
- NCT02921919
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-08
- Primary completion
- 2021-07-20
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.